PT-141
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and a metabolite analogue of Melanotan-II. It acts as a non-selective melanocortin receptor agonist and is studied within melanocortin-pathway research. Supplied in premium lyophilised format with every batch independently verified.
What is PT-141?
PT-141 (Bremelanotide) is a synthetic cyclic peptide derived from the melanocortin-agonist family. It is supplied here in premium lyophilised form for laboratory research use only.
Areas of research interest
Published preclinical research has explored PT-141 in connection with:
- Melanocortin-receptor signalling research in cell and animal models
- Studies of melanocortin-pathway analogues
- Receptor-binding and structure-activity research
Research context
Laboratory and animal studies have investigated PT-141 in connection with melanocortin-receptor signalling pathways. These observations are derived from preclinical research and have not been established in humans. This information is provided solely as a research reference.
Specifications
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Vial content: 10 mg lyophilised powder
- Purity: ≥98% by HPLC
- Molecular weight: 1,025.2 g/mol
- Storage: 2–8 °C prior to reconstitution
- Research use only
Quality Assurance
Every Syngeve compound is independently tested and supplied with a certificate of analysis. Average purity 99%+. Each batch undergoes third-party HPLC and mass-spectrometry verification before dispatch.
Certificate of Analysis
A batch-specific certificate of analysis is included with every order.
Shipping
Dispatched within 24 hours in discreet, tamper-evident, insulated packaging.
For research purposes only, where permitted by local regulations. Not for human consumption. This product is not a medicine and is not intended to diagnose, treat, cure, or prevent any disease.
